Facebook Linkedin Mail Twitter Youtube
Facebook Linkedin Mail Twitter Youtube
    Latest

    Features

    Demonstrating the case for inpatient prehab and rehab for advanced heart failure

    Gene therapy: A new solution to coronary graft failure?

    Cardiovascular News’ most-read stories of 2025

    heart attacks

    Report seeks to level the playing field for women in heart valve care

    Medtech Insights: Edwards’ Brüls outlines company’s move to specialise on structural heart disease

    New focus on education needed to improve uptake of intracoronary imaging

    Tackling unacceptable mortality in aortic stenosis: A call to expand TAVI access

    Challenges of 21st century aortic education, innovation and evidence get top billing at CX 2025

    Heart teams digest role of early aortic intervention following EARLY TAVR and EVOLVED trials

    Cardiovascular News’ most-read stories of 2024

    Robotic aortic valve replacement offers an “exciting new chapter” in the treatment of aortic valve disease

    Attention turns to multi-organ denervation as new evidence supports “durability” of blood pressure reductions

    EACTS past president puts innovation and inclusivity at the top of the agenda

    What they don’t teach in fellowship: Business insights for young cardiologists

    Will the NHS broaden its commissioning criteria for TEER?

    renal denervation

    Money-maker or meritable: Is renal denervation out of retirement?

    “There’s no meeting like it”: Stage is set for CX Aortic Live 2024

    Research aims to understand training needs for left-handed cardiac surgeons

    Medtech Insights: Trial pipeline underpins growth strategy for Watchman LAAC device

    Medtech Insights: Transcatheter tricuspid therapies “on the cusp of becoming standard of care”

    Debates to unpick controversies in aortic repair at CX 2024

    Renal denervation finds new shores following US FDA device approvals

    Settling the paclitaxel versus sirolimus DCB debate

    Challenges establishing minimally invasive cardiac surgery in the developing world

    Cardiovascular News’ top stories of 2023

    Profiling plaque to guide treatment of coronary artery disease

    EACTS panel sounds call to action over sex disparities in coronary surgery

    Low-risk TAVI trials underscore optimism for transcatheter approach but surgical societies reserve caution

    Data and debate to bring new light to aortic controversies at CX 2024

    Sham-controlled trials prompt renal denervation hypertension guideline update

    STS risk calculator uses power of big data to predict cardiac surgery risk

    “Not just inventing the next stent”: The future of medtech relies on patient empowerment

    EACTS puts innovation to the fore

    Timeline: Key milestones in the paclitaxel story

    Finding the roots of the disease before treating it: Modelling NSTEMI

    Renal denervation “can reach new shores”

    Cardiovascular-aortic community comes together at CX 2023

    interventional cardiology trials

    The interventional cardiology trials to watch in 2023

    Multidisciplinary teams at the heart of new guidelines on aortic disease management

    Cardiovascular News’ top stories of 2022

    Improved follow-up care needed for Black patients post-PCI to prevent hospital readmission and death

    Aortic advances: New techniques and technologies in the spotlight

    Minimally invasive aortic perfusion cannula receives EACTS Techno-College innovation award

    CX Aortic Vienna

    CX Aortic Vienna: Cardiac and vascular surgeons collaborate at the vanguard of aortic care

    Spotlight turns to TAVI in patients with moderate aortic stenosis

    Female representation in interventional cardiology remains low, but there is cause for hope

    “TAVI was my baby, now it is a teenager”

    Putting “stent regret” behind us

    Cardiologists without borders

    CX returns to in-person format once more in the London spring

    CX 2022 returns to in-person format facing challenges and opportunities in the aortic field

    New data underpin drive towards earlier AF ablation strategies

    Expanded robotic training will benefit cardiovascular care

    Portsmouth Hospital: How tech is guiding decision-making in the cath lab

    Abbott’s Nick West points to future role of AI in the cath lab

    Timir K Paul

    Downgraded guideline recommendations on embolic protection during saphenous vein graft intervention are a step in the right direction   

    “Tantalising” data open the door for further study of mechanical aspiration thrombectomy with PCI

    Understanding the risk of acute kidney injury in the cath lab

    What to expect from AHA 2021

    Lessons from SURTAVI

    Type A dissection enters a new revolution

    Philips’ Bert van Meurs discusses the future of imaging in the cath lab

    CX Aortic Vienna

    Cardiac, vascular and endovascular leaders convene for CX Aortic Vienna

    Renal denervation: The most advanced and efficacious interventional approach to treat hypertension

    Back in the room: A welcome return to in-person education

    Targeted healing: A new stent concept that could contribute to shortened DAPT

    Intravascular lithotripsy: Not an eccentric option for eccentric calcium

    RE-ACCESS study has implications for TAVI valve selection

    FAST II underscores vFFR as a “faster and easier” physiological lesion assessment tool

    Leaflex: Changing the conversation around aortic stenosis?

    Preventing kidney damage in the cath lab

    Cardiothoracic surgeons mobilised for COVID-19 research

    Understanding trends in TAVI and surgical aortic valve replacement

    How the LightLab initiative is examining the value of OCT in the cath lab

    CardioRisk: Addressing atherosclerotic risk factors among Egypt’s ACS patients

    IVL is a safe and predictable tool against coronary calcium

    What role will remote robotic procedures play in the future of PCI?

    Robotic treatment starts with the heart

    Minimally invasive aortic valve surgery or TAVI: The need for randomised trials

    ADVERTORIAL: What does SCOPE II tell us about TAVI device trials?

    Sharing international insight to improve the cardiovascular treatment pathway

    Optimising pharmacology after transcatheter aortic valve replacement: Lessons from the POPular TAVI trial

    The benefits of optical coherence tomography in the cath lab

    Late-breaking science is alive and well despite the pandemic

    Raising the bar for competency in high-risk coronary procedures

    Assessing non-obstructive coronary disease in the cath lab: A tailored approach to treat anginal symptoms

    ESC 2020 Congress: Digital platform takes congress to a wider audience

    Digital learning is becoming a part of the “new normal”

    Using remote learning to improve high-risk PCI outcomes

    Use of Impella CP is feasible in patients with severe aortic stenosis during high-risk percutaneous coronary intervention

    Using telemedicine to transform the management of acute myocardial infarction: the Latin America telemedicine infarct network (LATIN) experience

    COVID-19 is “here to stay” and new registry will provide important insights

    Transcatheter tricuspid valve repair shows promise for reducing heart failure hospitalisations

    COVID-19: “Communities of colour are at ground zero for this crisis”

    COVID-19: Education in the time of coronavirus

    COVID-19: We have used YouTube to encourage STEMI patients to come to hospital

    Using the heart team approach for congenital heart disease benefits both patients and parents

    COVID-19: Robotics may help to reduce exposure to virus patients during interventional procedures

    COVID-19: How the Egyptian cardiology departments are managing the pandemic

    COVID-19: Optimising heart failure management in the patient’s home

    Cancer patients should not automatically be excluded from TAVI

    Soft robotic heart could be answer to donor heart shortage

    Techno-College Innovation Award for LifeMatrix bioengineering platform

    Novel device “safely obliterates” left atrial appendage with minimal amount left behind

    Approval of Tendyne TMVI device means physicians now have a portfolio of options for treating mitral regurgitation

    BIBA Briefings: Award for film raising awareness of aortic dissection

    “Our goal is to treat more patients with mitral regurgitation”

    EXCEL may damage relations between interventional cardiologists and cardiac surgeons

    Further innovation and research is required for thrombus aspiration in PCI

    BIBA Briefings: Sapien 3 becomes first TAVI valve to be approved for low-risk patients in both Europe and the USA

    BIBA Briefings: Longest and largest follow-up data for Watchman supports its role in stroke prevention

    Further innovation and research is required for thrombus aspiration in PCI

    ADVERTORIAL: Answering the question of durability is TAVI’s next challenge

    International medical graduates in US cardiovascular care are vital to healthcare in the USA and beyond

    ADVERTORIAL: Edwards PASCAL™ Transcatheter Valve Repair System is associated with a “striking” reduction in mitral regurgitation

    BIBA Briefings: Henry V can inspire us to develop innovative techniques for reducing radiation exposure

    Transseptal puncture techniques must be mastered if physicians wish to perform left-sided interventions

    AtriCure agrees to buy LARIAT developer SentreHEART

    ADVERTORIAL: Device and procedural innovations have led to improved efficiency with TAVI

    Novel repositionable TAVI valve has acceptable early clinical outcomes

    atman-shah-cardiology

    Video games can take cardiology training to the next level

    Renal denervation still holds strong potential as a therapy for hypertension

    Poll favours interventional radiologists to perform mechanical thrombectomy in lieu of neurointerventionalists

    Edwards Lifesciences drops Centera in favour of focusing on Sapien range

    Myval: India’s TAVI technology is now going global

    The findings on transcatheter aortic valve implantation in patients who are at low risk for cardiac surgery will usher in a new era for patients

    The influence of technology and robotics in the catheterisation laboratory is growing

    New Liverpool Centre for Cardiovascular Science established

    The evolution of PCR: milestones and achievements in its 30-year journey

    pascal repair

    ADVERTORIAL: Edwards PASCAL™ Transcatheter Valve Repair System is innovative

    A “crackdown” on alternative access for TAVI

    Manage the risk of complications in CTO-PCI

    Reconciling the contrasting findings on MitraClip, and implications for the management of functional mitral regurgitation

    ADVERTORIAL: The Edwards Cardioband™ Tricuspid Valve Reconstruction System is associated with considerable improvement in functional outcomes

    We need to embrace digital education and adapt it to improve patient care—reflections from the ESC

    Challenges of conducting a randomised clinical trials to prove the impact of mechanical circulatory support in cardiogenic shock

    ADVERTORIAL Early results for HAART 200 and HAART 300 Aortic Annuloplasty Devices are encouraging

    The Tricento transcatheter heart valve: A novel approach for the treatment of tricuspid regurgitation

    ADVERTORIAL: “We are now at a new era of TAVI where we have very high rates of device success”

    paclitaxel

    Without additional long-term and patient-level data, Katsanos et al’s conclusion is premature

    The first 60 years of cardiac pacing

    TAVI-proof procedures and device designs

    Orsiro may be the new benchmark for comparison in drug-eluting stent trials

    BASILICA: A new approach for preventing coronary obstruction in TAVI

    The resurgence of renal denervation

    EACTS 2018: From bench to bedside: Roundtrip for cell therapy in heart disease

    Pulmonary artery denervation: A novel approach to managing pulmonary hypertension

    TCT 2018: Multivessel NIRS is feasible, safe and can predict future events

    TCT 2018: Sham-controlled trial indicates indirect annuloplasty reduces mitral regurgitation

    ADVERTORIAL: Tricuspid annular reduction using Edwards Cardioband (TM) Tricuspid Valve Reconstruction System in a patient with severe tricuspid regurgitation and large coaptation gap

    The US should follow Europe’s lead and change guidelines on embolic protection in saphenous vein grafting

    ADVERTORIAL: Unique design and features of the ACURATE neo (TM) enable safe and efficient procedures

    The number of metallic layers affects efficacy of drug-coated balloons for in-stent restenosis

    ADVERTORIAL: Rethinking the future of cardiology imaging

    Revising the National Coverage Determination for TAVI: The real barrier to care is not volume requirements

    ADVERTORIAL: Edwards’ CardiobandTM Tricuspid Valve Reconstruction System: A new option for under-treated patients

    The risks and benefits of exercise after a myocardial infarction

    “Communication is key” when managing patients who seek discharge against medical advice

    Increased rate of acute myocardial infarction during pregnancy linked to increase in older mothers

    “Tricuspidisation” could be a potential approach to performing TAVI in certain patients with bicuspid valves

    Invasive strategy provides better outcomes for very elderly patients with NSTEACS

    Marital status may influence risk of cardiovascular outcomes after myocardial infarction

    “Wait-and-see” is not an option with the new device regulations

    MedShr: A physician-designed online platform for case discussion

    Leaflex Performer: A non-implant based treatment for aortic stenosis

    ADVERTORIAL: Edwards Cardioband™ Mitral Valve Reconstruction System—Reliably addressing annular dilatation

    The “absolute priority” is to develop onco-cardiology guidelines to help clinicians

    TVT 2018: New-generation TAVI devices perform well in patients with large annuli

    Cardiac Myosin-binding Protein C: Improving chest pain triage by using a novel marker of myocardial injury

    Third-generation drug-eluting stents and beyond: Where were we, where are we, and where we are heading

    ADVERTORIAL: ACURATE neo: A “very safe” TAVI system providing “extremely good results in almost all patients”

    Cardiology societies come together to provide key advice for dealing with ionising radiation

    ADVERTORIAL: Sentinel Cerebral Protection System provides reassurance to both physicians and patients

    ADVERTORIAL: Taking control of LDL-C when statin therapy is not enough

    SCAI 2018: 3D model could be used to predict paravalvular leak after TAVI

    Ticagrelor may be an effective tool for suppressing platelet reactivity after TAVI

    Take care from start to finish: Avoiding radial artery occlusion

    From the heart of the Andes to the hearts of children

    Study to explore shortest-ever duration of triple therapy after PCI

    Intravascular lithotripsy: A novel technology for treating calcified coronary stenoses

    Determining valve durability in the era of TAVI

    ADVERTORIAL: “All patients” should receive cerebral protection when undergoing TAVI procedures

    Team-centred approach is best way of determining need for PFO closure

    Acute iFR evaluation may be a valid approach for ruling out non-culprit lesions in STEMI patients

    TCT 2017: The HREVS study provides supportive evidence for the hybrid revascularisation approach

    Artificial intelligence is being explored as a new tool for diagnosing coronary artery disease

    “We really believe that the transradial approach is a better way to do cardiac catheterisations”

    Interventional cardiology in the Twitterverse

    TCT 2017: TMVI in mitral ring is a reasonable alternative for high-risk patients

    TCT 2017: Vivek Reddy on the final outcomes of PREVAIL and PROTECT-AF

    A bold new study could alter the orbit of elective PCI

    Non beta-blocker therapies are infrequently used in patients experiencing angina after PCI

    Combing intravascular ultrasound with multispectral fluorescence lifetime imaging may provide comprehensive insights into lesion formation

    Bioresorbable valves: Insights into a potential game-changing technology

    From SYMPLICITY HTN-1 to SPYRAL HTN-OFF MED: The story of renal denervation

    PCR LV 2017: The optimal modalities for imaging for mitral and tricuspid valve interventions

    Caucasians have a higher incidence of an out-of-hospital cardiac arrest but risk of death is higher in African Americans.

    ESC 2017: Further decreasing mortality after STEMI will be difficult

    ESC 2017: Alternative strategies needed for treating stenotic lesions in saphenous vein grafts

    Good care means ensuring patients are thoroughly informed

    The ATI score: A new tool to triage novel treatments in patients with myocardial infarction

    The need to determine the relevance of stent malapposition

    Ruby anniversary: 1977 – A remarkable year for kings and queens

    Several barriers need to be overcome to make “telestenting” feasible

    Ruby anniversary: The key revolutions of the past 40 years

    Study finds that initiatives to improve medication adherence after myocardial infarction do not work

    EuroPCR 2017: A “golden era” for valve disease therapies

    Patients benefit from participating in clinical trials

    Bicuspid aortic stenosis: TAVI’s next challenge

    EuroPCR 2017: PCI outperforms medical management for treatment of chronic total occlusions

    Ruby anniversary: Peculiarities about the world’s first PCI

    TVT 2017: “I predict a very exciting and bright future” for transcatheter valve therapies

    The need to determine the relevance of stent malapposition

    The role of nurses in ensuring a patient-focused TAVI service

    TAVI pacemaker issue is “an engineering problem that will be solved”

    ACC 2017: Dual anti-thrombotic approach has similar risk of bleeding to dual antiplatelet therapy

    Viagra may reduce cardiovascular outcomes after a first myocardial infarction

    Atherectomy is an important tool for optimising results of PCI in calcified lesions

    The implications of ABSORB II three-year results for the future of bioresorbable scaffolds

    Procedural complexity should be considered when deciding duration of dual antiplatelet therapy

    Understanding and managing functional tricuspid regurgitation

    Performing PCI in comatose survivors of cardiac arrest

    Combining MitraClip mitral valve repair with left atrial appendage occlusion is safe and feasible

    The management of leaflet thickening after TAVI remains controversial

    Perform PCI prior to TAVI in patients with both coronary artery disease and aortic stenosis

    Infection in the setting of STEMI

    Revised European guidelines on cardiovascular disease prevention: What you need to know

    Minimally invasive TAVI has “several potential benefits”

    Focusing on risk-adjusted mortality in public reporting produces misleading figures

    ADVERTORIAL: Enhanced deliverability means Trifecta™ valve is now easier to implant

    ADVERTORIAL: Know where you are with SyncVision technology

    Standardisation paper aims to enhance uniformity of FFR in clinical practice

    TAVI at the end of life: Knowing when it is futile

    Study indicates that anger or emotional upset can trigger a myocardial infarction

    Wrist-worn heart rate monitors have variable accuracy

    Simplified TAVI device may benefit patients with rheumatic heart disease

    Novel tricuspid therapy wins the 2016 EACTS Techno College Innovation Award

    An “opt-out” approach may encourage more patient participation in research

    NORSTENT shows bare metal stents have improved

    The role of fractional flow reserve in managing STEMI patients with multivessel disease

    “Keep it fast and simple” to avoid periprocedural stroke after TAVI

    Advertorial: iFR Scout pullback assessment is “much more discriminatory” than FFR pullback assessment

    What is required for TAVI to become the new gold standard?

    TAVI durability: A rose by any other name is still a rose

    Exploring the borders of TAVI

    Combined percutaneous treatment of aortic stenosis and mitral regurgitation is feasible

    Trials on newer generation drug-eluting stents in small coronary vessels needed

    Online medical information: A blessing or a curse?

    Go “slender” to reduce the rate of radial artery occlusions

    “Encouraging” results for transcarotid TAVI

    The risk of acute kidney injury during complex cardiac interventions: Rationale of the STRENGTH study

    Reducing aggressive and rude communication helps both doctors and patients

    A new percutaneous approach for managing mitral valve regurgitation

    A new percutaneous approach for managing mitral valve regurgitation

    More data in support of newer generation stents for high bleeding risk patients

    Exploring the role of P2Y12 inhibitor monotherapy after dual antiplatelet therapy

    The role of sutureless and rapid-deployment valves

    The SCOUT study: Transcatheter tricuspid repair

    Complete PCI in STEMI: An interventional paradigm shift

    Building the ideal heart team for transcatheter mitral valve interventions

    Training is the key to wider adoption of the transradial approach for PCI in the USA

    Retrograde coronary revascularisation in Europe to treat chronic total coronary occlusions

    The role of psychological support after a myocardial infarction

    Interventional cardiologists may have “a false sense of security” about radiation safety

    Previous guidelines were “overconfident” about benefits of P2Y12 inhibitor pre-treatment

    Helping Little Hearts to mend

    An interventional cardiologist’s view on left atrial appendage closure

    The risk of stroke in patients undergoing TAVI

    Use of fusion imaging during TAVI

    Further studies needed to find effective treatment for reperfusion injury

    Rediscovering the transfemoral approach for structural heart interventions

    Bifurcation lesions: When a two-stent technique is needed

    Getting to grips with social media

    Strut coverage: Optical coherence tomography and new stent technologies

    The second generation of drug-eluting stents with biodegradable polymers may have potential advantages

    The importance of the PLATINUM DIVERSITY trial

    The current status of transcatheter pulmonary valve replacement

    Non-invasive FFRCT could transform management of coronary artery disease

    Tips and tricks for achieving optimum results with a drug-coated balloon

    Robotic PCI could be used to reduce radiation exposure to the operator

    SERVE-HF could be a wake-up call for cardiologists about central sleep apnoea

    Exploring new transcatheter options for the mitral valve

    Tailoring dual antiplatelet therapy duration for an individual patient

    ICI meeting is a “fruitful ground for new developments” in interventional cardiology

    Performing TAVI in a hybrid operating room

    First transcatheter tricuspid valve replacement performed in the USA

    The data for thrombectomy are conflicting

    Drug-coated balloons for the management of coronary artery disease

    Transitioning from transfemoral to transradial: Why the transradial approach is here to stay

    The role of rotational atherectomy in contemporary PCI practice

    New approach for aortic valve replacement is feasible

    “Interventional cardiology is losing more than 50% of the talent pool”

    A less invasive approach to cardiac assist device therapy

    Pre-hospital therapeutic hypothermia may not be beneficial

    Coronary revascularisation in diabetic patients: Where do we stand?

    Increased use of left ventricular assist devices could improve heart failure survival

    The use of vascular robotic systems for PCI

    Managing mild paravalvular leak after TAVI

    A smartphone app to assist valve-in-valve procedures

    Echocardiographic essentials for TAVI

    Impaired cardiac baroreflex sensitivity predicts response to renal sympathetic denervation

    The transformation of the coronary stent

    PCI and bypass graft surgery: Which intervention and in whom?

    The future of patent foramen ovale closure after the RESPECT and PC trials

    Performing TAVI in patients with carotid artery disease

    Optimising care through the heart team approach

    Mitral valve repair in severe mitral regurgitation: An interventional cardiologist’s perspective

    Key factors for valve-in-valve procedural success

    Huge progress needs to be made before bioresorbable stents can replace permanent stents

    Transradial access will probably become the default primary PCI strategy

    Reducing periprocedural complications is key for the future use of TAVI in lower-risk patients

    Knowing the long-term benefits of renal denervation is a priority

    Optimising the management of older patients with STEMI

    Can we mend a broken heart?

    Using dobutamine stress echocardiography to identify true-severe aortic stenosis

    The evolution of percutaneous valve technology

    Predictors of cardiac death in patients with coronary chronic total occlusion not revascularised by PCI

    The National Cardiovascular Data Registry is a “national treasure”

    Psychological factors before and after renal denervation for resistant hypertension

    The economics of TAVI

    “New generation TAVI devices will push complication rates down”

    Can we reduce paravalvular regurgitation after TAVI?

    Pacemaker dependency after transcatheter aortic valve implantation

    Radiation exposure during coronary angiography via transradial or transfemoral approaches: Does operator experience matter?

    Is magnetic resonance imaging a useful tool to identify the cause of malignant ventricular arrhythmias?

    Are there gender-related factors influencing the outcome of TAVI patients?

    Percutaneous coronary intervention in patients with severe aortic stenosis: Implications for TAVI

    Primary PCI as a national reperfusion “strategy” for STEMI

    An inside view into the FAST trial

    New data from the SOURCE registry

    Balloon aortic valvuloplasty in the current era

    “MRI is more accurate than SPECT in detecting the presence of significant coronary artery disease”

    Do drug-eluting stents increase the rate of late stent thrombosis compared to bare metal stents in STEMI patients? The DESERT cooperation

    Prasugrel or ticagrelor should be administered to patients at clinical high risk for stent thrombosis

    “This is a very good time to hop on the wagon and learn about 3D echocardiography”

    Pioneer of interventional cardiology in China receives Ethica Award 2011

    Clinical vs. anatomical risk stratification following complex PCI

    “There is a great deal of excitement about renal denervation among interventional cardiologists”

    Identifying an alternative to drug-eluting stents for treating bifurcation lesions

    GATEWAY Registry: Addressing bleeding risk in patients with acute coronary syndrome

    First ESC/EACTS guidelines on coronary revascularisation

    The SOURCE registry in the context of PARTNER

    It is time for a SYNTAX-like trial for transcatheter valves

    Transcatheter mitral interventions: MitraClip and beyond

    Europe on the front line of transcatheter aortic valve advancement

    Alternatives to today’s drug-eluting stents

    Optical coherence tomography to detect incomplete tissue coverage of metallic stent struts

    Less strict heart rate control is effective

    Ostial left anterior descending arteria stenosis treated by percutaneous coronary intervention and Promus Element everolimus-eluting stent system

    Audio: Interview with Prof Didier Carrié

    Progress in transcatheter heart valve techniques

    Patients at limited compliance or non-responsiveness to double antiplatelet therapy

    Secondary prevention of cardiovascular disease in Europe: Prescribing pills is not sufficient

    (Drug-eluting?) Coronary stenting in patients on chronic oral anticoagulation

    Children: A forgotten population

    Mild heart failure: The REVERSE findings

    Opinion: “Why we prefer the minicrush as a two-stent strategy”

    Opinion: From here to JUPITER

    Heart failure guidelines focus on key research findings, clinical advances

    Opinion: The value of FAME

    New appropriateness criteria guide treatment of patients with heart blockage

    ACUITY one-year sub-analysis published

    New minimal-invasive aortic valve resecting tool

    ASH: ARB combinations effective across subgroups

    Babies’ rapid weight gain linked to higher blood pressure as adults

    Cardiology studies on the decline

    EU project will develop computer models of the heart

    Warfarin seriously underused despite efficacy in preventing stroke

    Treadmill therapy can improve mobility in stroke victims

    Survey reveals major gap between prevention guidelines and reality

    Elderly HF patients do not benefit from intensive medical therapy

    New ATHENA data suggest decrease in stroke risk with dronedarone for AF

    Omega-3 apparently beneficial in heart failure, but rosuvastatin fails

    ESC updates guidelines for STEMI, heart failure and pulmonary embolism

    Load more

    Most read

    Bernardo Cortese

    Roxana Mehran

    Patrick Myers

    Cardiovascular News

    Write to us
    Editorial: Will Date [email protected]
    Advertising: Hannah Shiels [email protected]


    United Kingdom:

    BIBA Medical, Europe
    526 Fulham Road, Fulham, London, SW6 5NR
    TEL: +44 (0)20 7736 8788
    Email: [email protected]

    United States:

    BIBA Medical, North America
    155 North Wacker Drive, Suite 4250, Chicago, IL 60606
    TEL: +1 949 723 9309
    Email: [email protected]

    Terms and Conditions | Privacy Policy

    Facebook Linkedin Mail Twitter Youtube